AllNewsPhotosVideos
Dechen Consulting Group, Inc.

Dcgi

Dcgi, Latest News

1,50,000 doses of Russian COVID vaccine Sputnik V reach Hyderabad - Hindi News | 1,50,000 doses of Russian COVID vaccine Sputnik V reach Hyderabad | Latest national News at Lokmatnews.in

National :1,50,000 doses of Russian COVID vaccine Sputnik V reach Hyderabad

As many as 1,50,000 doses of Russian COVID vaccine Sputnik V arrived at the Rajiv Gandhi International Airport in Hyderabad on Saturday. ...

Optimus Pharma launched a new Anti-Parkinson's Drug in India - Hindi News | Optimus Pharma launched a new Anti-Parkinson's Drug in India | Latest business News at Lokmatnews.in

Business :Optimus Pharma launched a new Anti-Parkinson's Drug in India

Optimus Pharma has announced today that it has received DCGI approval for its Anti-Parkinson's drug Safinamide. Safinamide is indicated as adjunctive treatment to levodopa/carbidopa in patients with Parkinson's disease (PD) experiencing "off" episode ...

Russian Sputnik V COVID-19 vaccine to be tested on 100 Indian volunteers - Hindi News | Russian Sputnik V COVID-19 vaccine to be tested on 100 Indian volunteers | Latest international News at Lokmatnews.in

International :Russian Sputnik V COVID-19 vaccine to be tested on 100 Indian volunteers

The Russian Sputnik V vaccine against COVID-19 will be tested in India on 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) told Sputnik on Thursday. ...

DCGI issues guidelines for pharma giants manufacturing COVID-19 vaccine - Hindi News | DCGI issues guidelines for pharma giants manufacturing COVID-19 vaccine | Latest national News at Lokmatnews.in

National :DCGI issues guidelines for pharma giants manufacturing COVID-19 vaccine

The Drugs Controller General of India (DCGI) has issued a new set of guidelines, focusing on safety, immunogenicity and efficacy parameters for pharma giants who are developing COVID-19 vaccines. ...

Use Itolizumab for moderate to severe COVID-19 patients: DCGI - Hindi News | Use Itolizumab for moderate to severe COVID-19 patients: DCGI | Latest national News at Lokmatnews.in

National :Use Itolizumab for moderate to severe COVID-19 patients: DCGI

New Delhi, July 11 The Drugs Controller General of India (DCGI) has okayed the use of Itolizumab (rDNA ... ...

DCGI orders state govts to prevent black-marketing & overpricing of COVID-19 drugs - Hindi News | DCGI orders state govts to prevent black-marketing & overpricing of COVID-19 drugs | Latest maharashtra News at Lokmatnews.in

Maharashtra :DCGI orders state govts to prevent black-marketing & overpricing of COVID-19 drugs

Anti-viral drug Remdesivir prescribed for Covid-19 patients are in short supply with chemists and distributors in the city, according ... ...

DCGI permits human clinical trials for COVID-19 vaccine of Zydus Cadila - Hindi News | DCGI permits human clinical trials for COVID-19 vaccine of Zydus Cadila | Latest national News at Lokmatnews.in

National :DCGI permits human clinical trials for COVID-19 vaccine of Zydus Cadila

The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI. ...

DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted emergency use' on COVID-19 patients - Hindi News | DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted emergency use' on COVID-19 patients | Latest national News at Lokmatnews.in

National :DCGI gives nod to Mylan labs to manufacture remdesivir for 'restricted emergency use' on COVID-19 patients

The Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for 'restricted emergency use' on hospitalised COVID-19 patients, a senior government official said on T ...